GLAXOSMITHKLINE

There are two Ebola vaccines currently in clinical trials.

Investors are still making bets on biotech firms researching Ebola.

A look at the experimental drugs and vaccines that may bring an end to the deadly outbreak.

America's first Ebola patient, Thomas Eric Duncan, died while being treated with a drug from a relatively unknown biotech company.

The company is already investigating alleged bribery in a number of Middle East countries, as well as Poland.

Some stocks jumped more than 20 percent in just one hour.

The British company's executives involved in the bribery case received suspended prison sentences on Friday.

GSK could ultimately face a multi-million dollar settlement payment or fine.

The current Ebola outbreak, which particularly affected West Africa, has so far claimed 1,427 lives in four countries. A cure for the virus is yet to be discovered.

NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.

GSK, which faces a series of corruption charges in countries across the globe, also suspended its distributors in Syria.

A British-American couple was hired by pharmaceutical giant GlaxoSmithKline to investigate the source of a sex tape.

The company has endured a rocky relationship with Beijing, but that doesn't mean it will disengage from the Chinese market.

But this won't deter them -- or other pharmaceutical companies -- from engaging the lucrative Chinese market.

The couple were hired as private investigators and are now caught up in the massive GSK bribery case.

Amid a bribery scandal, a sex tape of the former chief of the drugmaker's China unit spreads worry about shady business practices.

A GSK spokesman reportedly confirmed the tape existed but did not comment on how it related to the alleged bribery scandal.

The U.K.’s Serious Fraud Office has opened a formal criminal investigation into the pharmaceutical company's commercial practices.

The charges target executives and not the company itself but the mounting allegations suggest the drugmaker is far from safe.

Abbott, Novartis and Pfizer are all looking to buy their way to cost savings.

China's anti-corruption probes are going after foreign companies that are marking up prices.